Salmeterol
RxNorm 36117
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 36117 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: salmeterol.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing salmeterol (medicinal product)
(Atom ID: 9731446)
INPrescribable
Ingredient (IN):
Salmeterol
(Atom ID: 462008)
PTPrescribable
Designated preferred name (PT):
Salmeterol
(Atom ID: 462013)
FNPrescribable
Full form of descriptor (FN):
Salmeterol (substance)
(Atom ID: 462019)
PTPrescribable
Designated preferred name (PT):
Salmeterol-containing product
(Atom ID: 10820524)
Patient Education
Salmeterol Oral Inhalation
Salmeterol is used to control wheezing, shortness of breath, coughing, and chest tightness in people with chronic obstructive pulmonary disease (COPD; a group of lung diseases that includes chronic bronchitis and emphysema). It is also used along with an inhaled steroid medication to control wheezing, shortness of breath, coughing, and chest tightness and in adults and children 4 years of age and older with asthma. It is also is used to prevent bronchospasm (breathing difficulties) during exercise in adults and children 4 years of age and older. Salmeterol is in a class of medications called long-acting beta agonists (LABAs). It works by relaxing and opening air passages in the lungs, making it easier to breathe.
[Learn More]
* Please review the disclaimer below.